Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122976222 | 12297622 | 2 | F | 2015 | 20160711 | 20160422 | 20160718 | EXP | PHHY2016BR052381 | NOVARTIS | 91.00 | YR | F | Y | 80.00000 | KG | 20160718 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122976222 | 12297622 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | (PATCH 5 CM2), QD | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 122976222 | 12297622 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | (PATCH 10 CM2), QD | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 122976222 | 12297622 | 3 | C | STILNOX | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 122976222 | 12297622 | 4 | C | STILNOX | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 122976222 | 12297622 | 5 | C | EUTHYROX | LEVOTHYROXINE SODIUM | 1 | Oral | 125 MG, QD | 0 | 125 | MG | QD | |||||||
| 122976222 | 12297622 | 6 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 122976222 | 12297622 | 7 | C | INFLUENZA VACCINE | INFLUENZA VIRUS VACCINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122976222 | 12297622 | 1 | Dementia Alzheimer's type |
| 122976222 | 12297622 | 3 | Sleep disorder |
| 122976222 | 12297622 | 4 | Anxiolytic therapy |
| 122976222 | 12297622 | 5 | Hypothyroidism |
| 122976222 | 12297622 | 6 | Sleep disorder |
| 122976222 | 12297622 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122976222 | 12297622 | OT |
| 122976222 | 12297622 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122976222 | 12297622 | Abasia | |
| 122976222 | 12297622 | Agnosia | |
| 122976222 | 12297622 | Asthenia | |
| 122976222 | 12297622 | Dementia Alzheimer's type | |
| 122976222 | 12297622 | Dysstasia | |
| 122976222 | 12297622 | Limb deformity | |
| 122976222 | 12297622 | Nasopharyngitis | |
| 122976222 | 12297622 | Paraplegia | |
| 122976222 | 12297622 | Urinary tract infection | |
| 122976222 | 12297622 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122976222 | 12297622 | 1 | 201409 | 0 | ||
| 122976222 | 12297622 | 3 | 201409 | 0 | ||
| 122976222 | 12297622 | 6 | 201409 | 0 |